Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Medical Oncology (Northwood, London, England)|February 12, 2022
ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinomaGuoxin Hou, Zhimin Lu, Yanyu Bi, et al.Heliyon|September 25, 2024
Exploring the prognostic and therapeutic value of HIF1A in lung adenocarcinomaZhimin Lu, Yanyu Bi, Jialu Jiang, et al.Journal of Cancer Research and Clinical Oncology|November 23, 2020
Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagyYanyu Bi, Yiming Jiang, Xia Li, et al.Oncotarget|September 9, 2017
Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engagerYanyu Bi, Hua Jiang, Peng Wang, et al.Biomaterials|February 17, 2026
Mitochondrial fusion targeted supramolecular peptide hydrogel for gut neuroprotectionWei Sun, Lu Han, Yanyu Bi, et al.Nano Letters|May 13, 2025
Poly(methyl methacrylate) Nanosphere-Based Photocrosslinked Hydrogels with Ultralong Phosphorescence Lifetimes for High-Precision 3D PrintingZhipeng Zhao, Yanyu Bi, Yi Wu, et al.Scientific Reports|June 28, 2023
A novel approach for the analysis of single-cell RNA sequencing identifies TMEM14B as a novel poor prognostic marker in hepatocellular carcinomaDing Ma, Shuwen Liu, Qinyu He, et al.Gene|June 15, 2020
Mining topoisomerase isoforms in gastric cancerGuoxin Hou, Jingjing Deng, Xin You, et al.Oncotarget|December 20, 2015
Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinomaKesang Li, Xiaorong Pan, Yanyu Bi, et al.Cancer Immunology, Immunotherapy : CII|December 31, 2016
Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinomaCheng Chen, Kesang Li, Hua Jiang, et al.Pageof 2